On April 17, 2026, the Shenzhen Medical Academy of Research and Translation (SMART) and the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) co-hosted an academic exchange event at SMART in Shenzhen, bringing together more than 100 researchers, clinicians, and early-career scholars from both institutions. Professor Chak-sing Lau, Dean of HKUMed, and Professor Leo Poon, Associate Dean (Human Capital), visited with a delegation. They were welcomed by Professor Nieng Yan, Founding President of SMART, Dr. Xinhao Zhang, Deputy Party Secretary, and representatives from SMART.



During the visit, the HKU delegation toured SMART's facilities, gaining an overview of its work in basic research, clinical translation, core facilities, and talent development. Representatives from the Greater Bay Area International Clinical Trials Center (BAY TRIAL) and the Greater Bay Area International Clinical Trial Institute (GBAICTI) presented their collaborative model for advancing clinical trials across the region, highlighting the integration of Shenzhen–Hong Kong clinical resources, cross-border coordination, and the use of real-world data. Both sides expressed interest in expanding collaboration in clinical research, training, and data sharing to support the development and translation of innovative therapies and medical technologies.
Opening the joint symposium, Professor Nieng Yan highlighted the strong alignment between SMART and HKUMed in areas including infectious diseases, neurological disorders, rare diseases, public health, and AI-powered biomedical research. She noted that SMART is building an integrated model spanning basic research, translational science, and clinical application, while HKUMed brings strengths in clinical medicine, medical education, and the training of future healthcare leaders. Under their Memorandum of Understanding, the two institutions will continue to expand collaboration in talent development, academic exchange, and joint research, with the shared goal of advancing the Greater Bay Area as a globally competitive center for biomedical science.

Professor Nieng Yan, Founding President of SMART, delivered the welcome remarks
The symposium featured 19 presentations from researchers across SMART, HKUMed, and partner institutions, covering topics such as brain imaging, AI-driven clinical trials and disease screening, cryo-electron microscopy, spinal disorders, blood–brain barrier regulation, ultrasound-based therapies, drug development, and the impact of climate change on microbiome. Participants also exchanged views on research infrastructure, including the SMART-National Biobank of China (SMART-NBC), the LTS Preprint Server and the Translational Innovation Center (TIC).





In closing remarks, Professor Chak-sing Lau described the event as a strong starting point for deeper collaboration between Shenzhen and Hong Kong. He noted that both sides will establish regular exchange mechanisms and work to translate shared academic priorities into tangible outcomes.

Professor Chak-sing Lau, Dean of HKUMed, delivered the closing remarks
The event provided a platform for closer engagement in scientific research, technology transfer, and talent exchange. Looking ahead, SMART and HKUMed will continue to build on their partnership to support the development of the biomedical sector in the Greater Bay Area.
With the 2026 APEC Economic Leaders' Meeting set to take place in Shenzhen, new opportunities for international scientific collaboration are emerging. SMART will continue to expand partnerships with Hong Kong and beyond, contributing to global scientific progress and human health.